Skip to content

    Mold-Tek Packaging Limited

    MOLDTKPAC
    Capital Goods·28 Jul 2025
    Management Summary

    Mold-Tek Packaging Limited delivered a strong Q1 FY26, with revenue up 22% and net profit up 35%, driven by robust performance in Paint, Pharma, and Food & FMCG. EBITDA margin expanded to 19.7%. The company is actively expanding capacity in Pharma and Panipat, and diversifying its product mix to reduce seasonality, despite a temporary dip in the Lubricant segment.

    Highlights

    5
    • Revenue increased by 22% YoY, demonstrating strong overall growth.

    • EBITDA margin expanded to 19.7% from an 18-odd percentage last year, with EBITDA per kg growing by 29%.

    • Net profit surged by approximately 35% YoY, reflecting improved profitability.

    • The Pharma segment achieved PAT breakeven and grew 11% over Q4, with new commercial orders from key clients.

    • Food & FMCG segment recorded robust double-digit growth of 14-16%, driven by improved serviceability and diversification.

    Concerns

    3
    • The Lubricant segment experienced negative growth due to the general monsoon season.

    • Consumption of ice cream and yogurts fell drastically due to early rains in May, impacting a seasonal product category.

    • Uncertainty persists regarding the JSW/AkzoNobel business, with no formal announcement on business continuity.

    Key financials

    Single quarter

    05 metrics
    1. 01Revenue Growth22%
    2. 02EBITDA Margin19.7%
    3. 03EBITDA per kg Growth29.0%
    4. 04Net Profit Growth35%
    5. 05Per kg Sales Revenue₹211

    Segment breakdown

    Paint
    5,600 tons Volume
    Lubricants
    2,400 tons Volume Growth
    Food & Qpack
    3,200 tons Volume14.0% Growth
    Pharma
    190 tons Volume11% Growth
    IML
    77% Share of Value75% Share of Volume
    Non-IML
    23% Share of Value25% Share of Volume
    List

    Order Book

    medium confidence

    Total Value

    45,000 tons

    as of 2026-03-31

    range

    Composition

    Mix3 products
    • Paint (FY26 Target)22,000 tons94.9%
    • Pharma (FY26 Target)190 tons0.8%
    • Panipat Food & FMCG (FY26 Target)1,000 tons4.3%

    Share of order book by product (derived from disclosed amounts)

    "The company's volume outlook for the full year is 43,000-45,000 tons, with specific targets for Paint, Pharma, and Food & FMCG segments."

    Source:
    Inferred

    Capital allocation

    1
    medium confidence
    CategoryHeadline
    Capex

    ₹90 crores

    Guidance & targets

    12
    CategoryTargetPriority
    Revenue
    Overall Revenue Growth
    12-15% value growth or 18-20% revenue growth
    Medium
    Pharma Revenue
    Pharma Revenue
    INR35 crores
    High
    Pharma Revenue
    Pharma Revenue
    INR50 crores to INR60 crores
    Medium
    Paint Volume
    Paint Volume
    21,000 to 22,000 tons
    Medium
    Panipat Food & FMCG Capacity
    Panipat Food & FMCG Capacity
    1000 tons
    High
    Panipat Food & FMCG Capacity
    Panipat Food & FMCG Capacity
    1500 tons to 1800 tons
    High
    Overall Capacity
    Total Capacity
    61,500 to 70,000 tons
    High
    Pharma Capacity
    Pharma Production Capacity
    2,000 tons
    High
    Pharma Capacity
    Pharma Production Capacity
    3,000, 3,500 tons
    Medium
    IML/Non-IML Mix
    IML Share of Total Volume
    80% plus
    Medium
    Food & FMCG Volume Growth
    Food & FMCG Volume Growth
    20%
    Medium
    Recycled Content Utilization
    Recycled Content Utilization
    20%
    High

    Pharma commercial order conversion

    next few quarters
    CurrentSeveral approvals received, some commercial orders started.
    TargetIncreased commercial orders and revenue contribution.

    Why it matters

    Crucial for achieving the ambitious INR35 crore Pharma revenue target for FY26.

    And going forward, several approvals are – which have been received in the last 3, 4 months, we'll start turning into commercial orders, improving the numbers in a better pace in the next few quarters.

    How to verify

    key_financials.segment_breakdown[name='Pharma'].metrics[label='Revenue']

    Risks & concerns

    4
    RiskSeverity

    Seasonal impact on Lubricant and Food & FMCG (Ice Cream/Yogurt) sales

    Lubricant segment saw negative growth due to monsoon, and ice cream/yogurt consumption fell due to early rains.Management acknowledged

    medium

    Uncertainty in JSW/AkzoNobel business

    No formal announcement on business continuity after JSW acquired AkzoNobel, creating uncertainty.Analyst acknowledged

    low

    Time-consuming Pharma approval process

    Pharma product approvals and commercial orders take a long time, though Mold-Tek is progressing well.Management acknowledged

    low

    Export duty structure clarity

    Clients in export markets (e.g., Bangladesh) are waiting for clarity on duty structures before placing firm orders.Management acknowledged

    medium

    Q&A highlights

    8

    “Aditya Birla is the main contributor for our growth is that much I can tell. However, even Asian Paints and other companies like; AkzoNobel and KNP maintained -- if not a positive growth and neutral growth or sustain the same levels of the previous quarter.”

    Clarifies the primary driver of strong paint segment growth, indicating market share gains with a key client.

    asked by Jaiveer Shekhawat

    2 min read7 chapters

    Detailed Narrative

    01

    Q1 FY26 Performance Overview

    Mold-Tek Packaging reported a strong Q1 FY26 with a 22% increase in revenue and a 35% rise in net profit. The EBITDA margin expanded to 19.7% from approximately 18% in the previous year, with EBITDA per kg growing by 29%. This performance was driven by robust growth across most segments, particularly Paint, Pharma, and Food & FMCG.

    02

    Segmental Growth Drivers

    The Paint segment saw significant growth, primarily led by Aditya Birla, while Asian Paints maintained stable volumes. The Pharma segment achieved breakeven at the PAT level and grew by 11% over Q4 FY25, with new commercial orders from clients like Invincea, MN, Laurus Labs, and Pulse. Food & FMCG recorded double-digit growth of 14-16%, benefiting from improved serviceability and diversification into non-seasonal products like Surf Excel and Horlicks.

    03

    Capacity Expansion and Utilization

    The company is actively expanding its manufacturing capabilities. In Pharma, new land (2.5 acres) has been acquired for future expansion, with current capacity of 1,500 tons targeted to reach 2,000 tons in the immediate quarters and 3,000-3,500 tons by next financial year. The Panipat facility, currently at 78% utilization, will start thin wall food product production in August and is expected to reach 7,000 tons by FY end. Cheyyar's utilization is at 68% and is improving with the shift of Gulf production.

    04

    Product Mix and Profitability

    The improved product mix, with higher contributions from Pharma and Food & FMCG, significantly boosted profitability, as evidenced by the per kg sales revenue increasing from INR198 to INR211. The IML (In-Mold Labeling) share in total value terms increased to 77% from 70% in Q1 last year, contributing to better margins. The company aims for IML to reach over 80% of total volume.

    05

    Operational Efficiency and Just-in-Time

    Investments in enhanced printing and die-cutting capacities have improved supply connectivity, reducing lead times for new products and artwork development from 3-4 weeks to 7-10 days. This just-in-time capability helps manage inventory better and respond faster to client demands, especially during peak seasons.

    06

    Export Market Expansion

    Mold-Tek is actively pursuing export opportunities in regions like Bangladesh, Europe, and the U.S. While trial quantities have been supplied, firm orders are pending clarity on duty structures. The company plans to participate in the European Pharma Exhibition in October to generate new leads and expand its product range for exports.

    07

    Recycled Content and Sustainability

    The company is increasing its utilization of recycled content (RCP), having already crossed 7,000-7,500 tons in the current financial year and targeting 20% utilization for the full year. This initiative is supported by improved product quality from suppliers and contributes to sustainability efforts.

    This is an AI-generated summary of a publicly available earnings call transcript. It is for informational purposes only and does not constitute investment advice, a recommendation, or an endorsement. inve.money is not a SEBI-registered investment advisor. Please consult a qualified financial advisor before making any investment decisions.